Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Migraine Excellence Forum

Migraine
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Dr Diamond
Videos
What to Expect at the Migraine 360 Training Course With Dr Diamond
04/18/2022
Merle Diamond, MD, shares "what to expect" at the Migraine 360 Primary Care Training Course that will explore best practices for diagnosis, options for acute and preventive management, and more.
Merle Diamond, MD, shares "what to expect" at the Migraine 360 Primary Care Training Course that will explore best practices for diagnosis, options for acute and preventive management, and more.
Merle Diamond, MD, shares "what...
04/18/2022
Neurology
Conference Coverage
Novel Therapeutic Targets for Migraine: Recent Findings
07/14/2021
In this video, Amynah Pradhan, PhD, Associate Professor, Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, discusses her State of Science presentation given at Neurology Week. Dr. Pradhan describes recent...
In this video, Amynah Pradhan, PhD, Associate Professor, Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, discusses her State of Science presentation given at Neurology Week. Dr. Pradhan describes recent...
In this video, Amynah Pradhan,...
07/14/2021
Neurology
Pharmacologic Management of Migraine in the ED: Opioid Use Decreased From 2010 to 2017
Q&As
Pharmacologic Management of Migraine in the ED: Opioid Use Decreased From 2010 to 2017
03/09/2021
Neurology Learning Network spoke with Philip Wang, whose study recently demonstrated that, for emergency department visits for migraine between 2010 and 2017, opioid prescriptions decreased and administration of guideline-recommended...
Neurology Learning Network spoke with Philip Wang, whose study recently demonstrated that, for emergency department visits for migraine between 2010 and 2017, opioid prescriptions decreased and administration of guideline-recommended...
Neurology Learning Network spoke...
03/09/2021
Neurology
Headache Medicine: What's on the Horizon for 2021?
Videos
Headache Medicine: What's on the Horizon for 2021?
01/27/2021
In this video, Stephanie Nahas, MD, MSEd, discusses anticipated developments in headache medicine this year, including new indications for pharmacologic therapies, the use of devices, advocacy, and more. A full transcript is provided.
In this video, Stephanie Nahas, MD, MSEd, discusses anticipated developments in headache medicine this year, including new indications for pharmacologic therapies, the use of devices, advocacy, and more. A full transcript is provided.
In this video, Stephanie Nahas,...
01/27/2021
Neurology
Embracing Telemedicine During COVID-19: Key Takeaways for Headache Specialists
Videos
Embracing Telemedicine During COVID-19: Key Takeaways for Headache Specialists
01/15/2021
In this video, Stephanie Nahas, MD, MSEd, reviews take-home messages for headache specialists on the use of telemedicine. A full transcript is provided.
In this video, Stephanie Nahas, MD, MSEd, reviews take-home messages for headache specialists on the use of telemedicine. A full transcript is provided.
In this video, Stephanie Nahas,...
01/15/2021
Neurology
Headache Medicine: Navigating the Highs and Lows of 2020
Videos
Headache Medicine: Navigating the Highs and Lows of 2020
12/29/2020
In this video, Neurology Learning Network’s Migraine Section Editor Stephanie Nahas, MD, reviews key developments in the field of headache and migraine this year, including new therapeutics, virtual conferences, and more. A full transcript is...
In this video, Neurology Learning Network’s Migraine Section Editor Stephanie Nahas, MD, reviews key developments in the field of headache and migraine this year, including new therapeutics, virtual conferences, and more. A full transcript is...
In this video, Neurology...
12/29/2020
Neurology
Pearls for Managing Migraine via Telemedicine During COVID-19
Videos
Pearls for Managing Migraine via Telemedicine During COVID-19
12/17/2020
In this video, Stephanie Nahas, MD, MSEd, offers strategies that could help improve the telemedicine experience for both patients and providers when caring for patients with migraine during the ongoing pandemic.
In this video, Stephanie Nahas, MD, MSEd, offers strategies that could help improve the telemedicine experience for both patients and providers when caring for patients with migraine during the ongoing pandemic.
In this video, Stephanie Nahas,...
12/17/2020
Neurology
Telemedicine: Successes and Challenges in Treating Migraine During COVID-19
Videos
Telemedicine: Successes and Challenges in Treating Migraine During COVID-19
12/08/2020
In this video, Stephanie Nahas, MD, MSEd, discusses the pros and cons of telemedicine for the management and treatment of migraine during the ongoing pandemic.
In this video, Stephanie Nahas, MD, MSEd, discusses the pros and cons of telemedicine for the management and treatment of migraine during the ongoing pandemic.
In this video, Stephanie Nahas,...
12/08/2020
Neurology
The “Silver Linings” of the Pandemic for Patients With Migraine
Videos
The “Silver Linings” of the Pandemic for Patients With Migraine
11/25/2020
In this video, Stephanie J. Nahas, MD, MSEd, discusses how the ongoing pandemic has affected symptoms, management, and treatment among patients with migraine.
In this video, Stephanie J. Nahas, MD, MSEd, discusses how the ongoing pandemic has affected symptoms, management, and treatment among patients with migraine.
In this video, Stephanie J....
11/25/2020
Neurology
Managing Migraine During COVID-19: The Benefits of Telehealth
Videos
Managing Migraine During COVID-19: The Benefits of Telehealth
11/17/2020
In this video, Regina Krel, MD, discusses what can and cannot be accomplished in a telehealth visit for the management of migraine during the COVID-19 pandemic.
In this video, Regina Krel, MD, discusses what can and cannot be accomplished in a telehealth visit for the management of migraine during the COVID-19 pandemic.
In this video, Regina Krel, MD,...
11/17/2020
Neurology

Advertisement

Advertisement

News

Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement